General F.D.A. Panel’s Vote on Peptides Raises Concerns About a Prescribing BoomBy Healthcare Propulsion StaffJuly 24, 20260 A Food and Drug Administration advisory panel recommended broader use of six unproven peptides, raising concerns that wellness and telehealth…
General A Peptide Showdown: F.D.A. Scientists May Clash With R.F.K.’s AgendaBy Healthcare Propulsion StaffJuly 23, 20260 A Food and Drug Administration advisory committee hearing on Thursday and Friday may set Health and Human Services Secretary Robert…
